# Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP

> **NCT05018871** · PHASE1 · SUSPENDED · sponsor: **The Foundation for Orthopaedics and Regenerative Medicine** · enrollment: 15 (estimated)

## Conditions studied

- Cerebral Palsy

## Interventions

- **BIOLOGICAL:** autologous adipose derived mesenchymal stem cells

## Key facts

- **NCT ID:** NCT05018871
- **Lead sponsor:** The Foundation for Orthopaedics and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-12
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 15 (ESTIMATED)
- **Why stopped:** Covid-19
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018871, "Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05018871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*